Full-Time
Senior Data Engineer
I, II, III
Confirmed live in the last 24 hours
Cellares
201-500 employees
Develops and manufactures cell therapies efficiently
Compensation Overview
$90k - $210kAnnually
Senior
San Bruno, CA, USA
Hybrid position based in South San Francisco.
- Bachelor's or Master's degree in Computer Science, Engineering, or a related technical field with at least 6 years of related industry experience
- Proven experience in data engineering, with a focus on building data pipelines and infrastructure in cloud environments, preferably on Microsoft Azure
- Strong proficiency in Azure services such as Azure Databricks, Azure Database for PostgreSQL, Azure Table Storage, Azure Cosmos DB
- Proficiency in managing, optimizing, and data integration with Elasticsearch clusters
- Experience with data preprocessing, feature engineering, and data modeling techniques, particularly in the context of data analytics, machine learning, and AI applications
- Proficiency in programming languages such as Python or C#, with experience in developing scalable and efficient data processing code
- Expertise with data visualization tools such as Microsoft Power BI and Tableau
- Familiarity with data governance, compliance, and security best practices, especially in regulated industries such as medical devices, cell therapy, bioprocessing, or instrumentation
- Excellent problem-solving and analytical skills, with the ability to troubleshoot complex data engineering issues and optimize performance
- Effective communication and collaboration skills, with the ability to work in cross-functional teams and interact with stakeholders at all levels
- Comfortable working in a fast-paced start-up company environment with minimal direction and changing priorities
- Ability to be a strong problem solver and team player
- Self-awareness, integrity, authenticity, and a growth mindset
- Architect, design, and implement data pipelines and infrastructure to support the implementation of data analytics and AI solutions, leveraging Azure Cloud Platform and Databricks technologies
- Collaborate with cross-functional teams to understand project requirements, translate them into technical specifications, and develop scalable and efficient data solutions
- Build and maintain data ingestion, transformation, and storage systems using Azure services such as Azure Database for PostgreSQL, Azure Blob storage, and Azure Databricks, ensuring data quality, reliability, and security
- Work closely with cell therapy process developers, manufacturing operators, and scientists to preprocess and prepare data for machine learning models, performing feature engineering, data augmentation, and exploratory data analysis as needed
- Implement monitoring, logging, and alerting mechanisms to track data pipeline performance and ensure timely identification and resolution of issues
- Document data engineering processes, workflows, and best practices and provide guidance and support to project team members as needed
Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO) that combines these processes in one facility. Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity, reduces costs, and lowers process failure rates compared to traditional methods. The company serves a range of clients, including preclinical, clinical, and commercial entities, and has partnerships with major pharmaceutical companies for CAR-T cell therapy manufacturing. Cellares aims to provide efficient and cost-effective manufacturing services, distinguishing itself from competitors in the biotechnology industry.
Company Stage
Series C
Total Funding
$345.3M
Headquarters
South San Francisco, California
Founded
2019
6 month growth
↑ 9%1 year growth
↑ 32%2 year growth
↑ 86%
Simplify's Take
What believers are saying
- The $380M worldwide capacity reservation and supply agreement with Bristol Myers Squibb underscores Cellares' strong market position and growth potential.
- The launch of Cell Q, the world's first automated cGMP QC workcell, demonstrates Cellares' commitment to innovation and operational efficiency.
- The addition of industry veteran Christi Shaw to the advisory board brings invaluable expertise and leadership to the company.
What critics are saying
- The complexity of integrating advanced technologies like the Cell Shuttle and Cell Q could lead to operational challenges and delays.
- The highly competitive biotechnology sector requires continuous innovation to maintain a leading position, which can be resource-intensive.
What makes Cellares unique
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO), combining development and manufacturing processes under one roof, unlike traditional CDMOs.
- Their proprietary 'Smart Factory' technology, including automated single-use cartridge systems, significantly boosts productivity and reduces costs and process failure rates.
- Strategic partnerships with major pharmaceutical companies like Bristol Myers Squibb and Lyell highlight their industry credibility and advanced capabilities.
Help us improve and share your feedback! Did you find this helpful?